COGENT BIOSCIENCES

Cogent Biosciences uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and efficacy. Unum is seeking partners interested in using the ACTR technology to arm proprietary tumor-specific antibodies with a T-cell to improve their therapeutic potential. The company is headquartered in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

COGENT BIOSCIENCES

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Health Care Medical Therapeutics

Founded:

2014-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.cogentbio.com

Total Employee:

101+

Status:

Active

Contact:

(617) 843-5032

Email Addresses:

[email protected]

Total Funding:

432.7 M USD

Technology used in webpage:

SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 AWS Global Accelerator

Similar Organizations

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

urovant-sciences-logo

Urovant Sciences

Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.

Current Advisors List

chris-cain_image

Chris Cain Board Member @ Cogent Biosciences
Board_member
2020-07-06

charles-wilson_image

Charles Wilson Board Member @ Cogent Biosciences
Board_member
2014-01-01

karen-ferrante_image

Karen Ferrante Board Member @ Cogent Biosciences
Board_member
2018-02-01

peter-harwin_image

Peter Harwin Board Member @ Cogent Biosciences
Board_member
2020-07-06

robert-perez_image

Robert Perez Board Member @ Cogent Biosciences
Board_member
2018-03-01

matthew-ros_image

Matthew Ros Board Member @ Cogent Biosciences
Board_member

jörn-aldag_image

Jörn Aldag Board Member @ Cogent Biosciences
Board_member
2016-02-01

bruce-booth_image

Bruce Booth Board Chairman @ Cogent Biosciences
Board_member
2014-09-01

Current Employees Featured

jessica-sachs_image

Jessica Sachs
Jessica Sachs Chief Medical Officer @ Cogent Biosciences
Chief Medical Officer
2019-07-01

charles-wilson_image

Charles Wilson
Charles Wilson President and CEO @ Cogent Biosciences
President and CEO
2014-03-01

dario-campana_image

Dario Campana
Dario Campana Scientific Founders @ Cogent Biosciences
Scientific Founders

geoffrey-hodge_image

Geoffrey Hodge
Geoffrey Hodge SVP Operations @ Cogent Biosciences
SVP Operations
2015-06-01

matthew-osborne_image

Matthew Osborne
Matthew Osborne CFO @ Cogent Biosciences
CFO
2019-06-01

Founder

dario-campana_image

Dario Campana

Stock Details

Company's stock symbol is NASDAQ:UMRX

Acquisitions List

Date	Company	Article	Price
2020-07-06	Kiq	Kiq acquired by Cogent Biosciences	N/A

Investors List

logos-capital_image

Logos Capital

Logos Capital investment in Post-IPO Equity - Cogent Biosciences

commodore-capital_image

Commodore Capital

Commodore Capital investment in Post-IPO Equity - Cogent Biosciences

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Post-IPO Equity - Cogent Biosciences

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Equity - Cogent Biosciences

rtw-investments-llc_image

RTW Investments LLC

RTW Investments LLC investment in Post-IPO Equity - Cogent Biosciences

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Post-IPO Equity - Cogent Biosciences

atlas-venture_image

Atlas Venture

Atlas Venture investment in Post-IPO Equity - Cogent Biosciences

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Cogent Biosciences

ally-bridge-group_image

Ally Bridge Group

Ally Bridge Group investment in Post-IPO Equity - Cogent Biosciences

bvf-partners_image

BVF Partners

BVF Partners investment in Post-IPO Equity - Cogent Biosciences

Official Site Inspections

http://www.cogentbio.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K

Host Informations
Whois Informations

Loading ...

More informations about "Cogent Biosciences" on Search Engine